Zusammenfassung
Die Haut ist Zielorgan allergischer Reaktionen auf kleinmolekulare Stoffe. Ein häufiges und starkes Kontaktallergen stellt para-Phenylendiamin (PPD) dar. Die Untersuchungen der letzten Jahre haben neue Erkenntnisse über die Abläufe bei der Sensibilisierung und allergischen Kontaktdermatitis auf PPD erbracht. Hierbei konnten wichtige Informationen über die Metabolisierung kleinmolekularer Stoffe in der Haut und deren Beteiligung bei der Aktivierung bzw. Deaktivierung immunogener Substanzen gewonnen werden. Molekularepidemiologische Studien weisen darauf hin, dass genetische Polymorphismen möglicherweise diese Vorgänge und damit das individuelle Sensibilisierungsrisiko beeinflussen.
Abstract
Due to its constant exposure to small molecular weight compounds, the skin is a major target for allergic reactions. Para-phenylenediamine (PPD) is a common and strong contact allergen. Recent studies have revealed new aspects of steps involved in sensitization and allergic contact dermatitis to PPD, giving insight into the cutaneous metabolism of small molecular compounds and its effect on activation and deactivation of immunogenic substances. Molecular epidemiological studies have suggested that polymorphisms in genes encoding cytokines (e.g. TNF-alpha) or metabolizing enzymes (e.g. N-acetyltransferase) may have influence on these mechanisms and the individual susceptibility for sensitization.
Literatur
Aeby P, Sieber T, Beck H et al (2008) Skin sensitization to p-Phenylenediamine: the diverging roles of oxidation and N-acetylation for dendritic cell activation and the immune response. J Invest Dermatol (in press)
Aeby P, Wyss C, Beck H et al (2004) Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. J Invest Dermatol 122:1154–1164
Allen MH, Wakelin SH, Holloway D et al (2000) Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis. Immunogenetics 51:201–205
Armstrong DK, Jones AB, Smith HR et al (1999) Occupational sensitization to p-phenylenediamine: a 17-year review. Contact Dermatitis 41:348–349
Baron JM, Holler D, Schiffer R et al (2001) Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 116:541–548
Basketter D, Dooms-Goossens A, Karlberg AT, Lepoittevin JP (1995) The chemistry of contact allergy: why is a molecule allergenic? Contact Dermatitis 32:65–73
Belsito DV (2000) The diagnostic evaluation, treatment and prevention of allergic contact dermatitis in the new millennium. J Allergy Clin Immunol 105:409–420
Blohm SG, Rajka G (1970) The allergenicity of paraphenylendiamine. I. Acta Derm Venereol 50:49–50
Blomeke B, Brans R, Dickel H et al (2008) Association between TNFA-308 G/A polymorphism and sensitization to para-phenylenediamine: a case-control study. Allergy (in press)
Blomeke B, Pietzsch T, Merk HF (2008) Elicitation response characteristics to mono- and to N,N’-diacetyl-para-phenylenediamine. Contact Dermatitis 58:355–358
Brans R, Dickel H, Bruckner T et al (2005) MnSOD polymorphisms in sensitized patients with delayed-type hypersensitivity reactions to the chemical allergen para-phenylene diamine: a case-control study. Toxicology 212:148–154
Cabrera M, Shaw MA, Sharples C et al (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182:1259–1264
Collins FS, Brooks LD, Chakravarti A (1998) A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 8:1229–1231
Coulter EM, Jenkinson C, Wu Y et al (2008) Activation of T-cells from allergic patients and volunteers by p-phenylenediamine and Bandrowski’s base. J Invest Dermatol 128:897–905
Hahn C, Roseler S, Fritzsche R et al (1993) Allergic contact reaction to dexpanthenol: lymphocyte transformation test and evidence for microsomal-dependent metabolism of the allergen. Contact Dermatitis 28:81–83
Heesen M, Kunz D, Bachmann-Mennenga B et al (2003) Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med 31:211–214
Hein DW (2002) Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 506–507:65–77
Hein DW, Doll MA, Fretland AJ et al (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9:29–42
Hulette BC, Ryan CA, Gildea LA, Gerberick GF (2005) Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicol Appl Pharmacol 209:159–166
Kawakubo Y, Merk HF, Masaoudi TA et al (2000) N-Acetylation of paraphenylenediamine in human skin and keratinocytes. J Pharmacol Exp Ther 292:150–155
Kawakubo Y, Nakamori M, Schopf E, Ohkido M (1997) Acetylator phenotype in patients with p-phenylenediamine allergy. Dermatology 195:43–45
Krasteva M, Nicolas JF, Chabeau G et al (1993) Dissociation of allergenic and immunogenic functions in contact sensitivity to para-phenylenediamine. Int Arch Allergy Immunol 102:200–204
Landsteiner K, Jacobs JL (1936) Studies on the sensitization of animals with simple chemicals. J Exp Med 64:625–639
Lichter J, Heckelen A, Fischer K, Blomeke B (2008) Expression of N-acetyltransferase in monocyte-derived dendritic cells. J Toxicol Environ Health A 71:960–964
Louis E, Franchimont D, Piron A et al (1998) Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113:401–406
Merk HF, Baron JM, Heise R et al (2006) Concepts in molecular dermatotoxicology. Exp Dermatol 15:692–704
Moeller R, Lichter J, Blomeke B (2008) Impact of para-phenylenediamine on cyclooxygenases expression and prostaglandin formation in human immortalized keratinocytes (HaCaT). Toxicology 249:167–175
Munday R (1988) Generation of superoxide radical, hydrogen peroxide and hydroxyl radical during the autoxidation of N,N,N’,N’-tetramethyl-p-phenylenediamine. Chem Biol Interact 65:133–143
Nacak M, Erbagci Z, Aynacioglu AS (2006) Human arylamine N-acetyltransferase 2 polymorphism and susceptibility to allergic contact dermatitis. Int J Dermatol 45:323–326
Nohynek GJ, Duche D, Garrigues A et al (2005) Under the skin: biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. Toxicol Lett 158:196–212
Picardo M, Zompetta C, Marchese C et al (1992) Paraphenylenediamine, a contact allergen, induces oxidative stress and ICAM-1 expression in human keratinocytes. Br J Dermatol 126:450–455
Rastogi SC, Sosted H, Johansen JD et al (2006) Unconsumed precursors and couplers after formation of oxidative hair dyes. Contact Dermatitis 55:95–100
Reiss F, Fisher AA (1974) Is hair dyed with para-phenylenediamine allergenic? Arch Dermatol 109:221–222
Ryan CA, Gerberick GF, Gildea LA et al (2005) Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol Sci 88:4–11
Schnuch A, Lessmann H, Frosch PJ, Uter W (2008) Para-Phenylenediamine: the profile of an important allergen. Results of the IVDK. Br J Dermatol 159:379–386
Schulz KH (1962) Allergien gegenüber aromatischen Amino- und Nitro-Verbindungen. Berufsdermatosen 10:69–91
Sieben S, Baron JM, Blomeke B, Merk HF (1999) Multiple cytochrome P450-isoenzymes mRNA are expressed in dendritic cells. Int Arch Allergy Immunol 118:358–361
Sieben S, Hertl M, Al Masaoudi T et al (2001) Characterization of T cell responses to fragrances. Toxicol Appl Pharmacol 172:172–178
Sieben S, Kawakubo Y, Al Masaoudi T et al (2002) Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. J Allergy Clin Immunol 109:1005–1011
Sieben S, Kawakubo Y, Sachs B et al (2001) T cell responses to paraphenylenediamine and to its metabolites mono- and diacetyl-paraphenylenediamine. Int Arch Allergy Immunol 124:356–358
Skazik C, Grannemann S, Wilbers L et al (2008) Reactivity of in vitro activated human T lymphocytes to p-phenylenediamine and related substances. Contact Dermatitis 59:203–211
Stanley LA, Skare JA, Doyle E et al (2005) Lack of evidence for metabolism of p-phenylenediamine by human hepatic cytochrome P450 enzymes. Toxicology 210:147–157
Uter W, Lessmann H, Richter G (2002) The spectrum of allergic (cross-)sensitivity in clinical patch testing with „para amino“ compounds. Allergy 57:319–322
Westphal GA, Reich K, Schulz TG et al (2000) N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy. Br J Dermatol 142:1121–1127
Westphal GA, Schnuch A, Moessner R et al (2003) Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermatitis 48:93–98
White JM, Kullavanijaya P, Duangdeeden I et al (2006) p-Phenylenediamine allergy: the role of Bandrowski’s base. Clin Exp Allergy 36:1289–1293
Witte JS, Palmer LJ, O’Connor RD et al (2002) Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma. Eur J Hum Genet 10:82–85
Zapolanski T, Jacob SE (2008) Avoiding paraphenylenediamine exposure in children. Pediatr Ann 37:104–105
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Brans, R., Skazik, C., Merk, H. et al. Sensibilisierung auf p-Phenylendiamin. Hautarzt 60, 26–31 (2009). https://doi.org/10.1007/s00105-008-1643-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-008-1643-7